𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New point mutation (R301X) of the α-galactosidase a gene causing fabry disease

✍ Scribed by Chiaki Kawanishi; Hitoshi Osaka; Ken Inoue; Hideki Onishi; Yoshiteru Yamada; Naoya Sugiyama; Kyoko Suzuki; Tokiji Hanihara; Tomohiro Miyagawa; Seiji Kimura; Susumu Kawamoto; Kenji Okuda; Kenji Kosaka

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
160 KB
Volume
6
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel acceptor splice site mutation in t
Novel acceptor splice site mutation in the invariant AG of intron 6 of α-galactosidase A gene, causing Fabry disease
✍ Takehiko Matsumura; Hitoshi Osaka; Naoya Sugiyama; Chiaki Kawanishi; Yasuko Maru 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

We found a novel acceptor splice site mutation in the invariant AG of intron 6 of a-galactosidase A (a-Gal A) gene (IVS6-1G->A) in a patient with Fabry disease by sequencing of genomic DNA. Sequencing of RT-PCR revealed the deletion of first base pair (c909del) of exon 7 in mRNA and a frameshift res

Identification of a novel point mutation
Identification of a novel point mutation (S65T) in α-galactosidase A gene in Chinese patients with Fabry disease
✍ Chia-Hsiang Chen; Pei-Wen Shyu; Su-Jen Wu; Song-Shan Sheu; Robert J. Desnick; Kw 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

Fabry disease is an X-linked inborn error of sphingolipid catabolism resulting from deficient enzyme activity of a-galactosidase A. The molecular defects of human a-galactosidase A gene causing Fabry disease have been characterized, including gene rearrangement and point mutations, which show the ge

A sensitive mutation screening strategy
A sensitive mutation screening strategy for Fabry disease: Detection of nine mutations in the α-galactosidase A gene
✍ Lianne C. Blanch; Cathy Meaney; C. Phillip Morris 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 660 KB

Fabry disease is an X-linked recessive lysosomal storage disorder caused by a deficiency of a-galactosidase A (a-gal; EC 3.2.1.22). In the past, it has been difficult to give an unequivocal diagnosis of carrier status in Fabry disease because of the overlap between normal and heterozygote enzyme lev

Detection of large gene rearrangements i
Detection of large gene rearrangements in X-linked genes by dosage analysis: identification of novel α-galactosidase A (GLA) deletions causing Fabry disease
✍ Robert Dobrovolny; Irina Nazarenko; Jungmin Kim; Dana Doheny; Robert J. Desnick 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB 👁 1 views

For most Mendelian disorders, targeted genome sequencing is an effective method to detect causative mutations. However, sequencing PCR-amplified exonic regions and their intronic boundaries can miss large deletions or duplications and mutations that lead to PCR failures in autosomal dominant disorde

A novel mutation (E358K) in the α-galact
A novel mutation (E358K) in the α-galactosidase A gene detected in a Japanese family with Fabry disease
✍ Dr. Takashi Miyazaki; Mitsuharu Kajita; Sachiko Ohmori; Naoki Mizutani; Toshimit 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

The enzyme deficiency causes the intralysosomal accumulation of glycosphingolipids. The affected hemizygotes manifest acroparethesis, angiokeratoma, hypohidrosis, corneal opacities, and progressive vascular diseases of the kidney, heart, and brain. The human a-Gal A cDNA (Bishop et al., 1986) and ge